SEC EDGAR Form 13F
Farallon Capital Management
Farallon Capital Management is a multi-strategy investment manager founded by Tom Steyer, with Form 13F filings covering reportable public-equity holdings.
Latest Form 13F: 173 long U.S. equity positions, $19.1B reported value for the period ended Mar 31, 2026, led by ELECTRONIC ARTS INC, STATE STR SPDR S&P 500 ETF T, and REVOLUTION MEDICINES INC.
CIK: 909661 · Filed: Aug 14, 2026 · Period: Mar 31, 2026
What a 13F does not show
Form 13F covers many reportable long U.S. equity positions at quarter end. It does not show every asset type, short positions, hedges, intraperiod trades, or current holdings after the report date. Use it as ownership context, not investment advice.
Read the 13F guide →Top reported holdings
Showing the top 50 positions by reported value. Source: SEC EDGAR Form 13F; period 2026-03-31; filed 2026-08-14.
| # | Ticker | Company | Shares | Value | Portfolio % | QoQ change |
|---|---|---|---|---|---|---|
| 1 | EA | ELECTRONIC ARTS INC | 7.5M | $1.5B | 100.00% | -- |
| 2 | -- | STATE STR SPDR S&P 500 ETF T | 2.3M | $1.5B | 8.53% | -- |
| 3 | RVMD | REVOLUTION MEDICINES INC | 13.6M | $1.3B | 7.54% | -6.7% |
| 4 | AMZN | AMAZON COM INC | 4.2M | $879M | 5.01% | -6.3% |
| 5 | MSFT | MICROSOFT CORP | 2.3M | $868M | 4.95% | +5.9% |
| 6 | AON | AON PLC | 2.5M | $811M | 4.62% | -5.7% |
| 7 | BBIO | BRIDGEBIO PHARMA INC | 9.4M | $695M | 3.96% | +4.1% |
| 8 | -- | INVESCO EXCHANGE TRADED FD T | 3.6M | $691M | 3.94% | -- |
| 9 | PTGX | PROTAGONIST THERAPEUTICS INC | 6.3M | $669M | 3.81% | +3.3% |
| 10 | NTRA | NATERA INC | 3.2M | $641M | 3.66% | -18.1% |
| 11 | EXEL | EXELIXIS INC | 13.1M | $562M | 3.21% | -16.5% |
| 12 | AVGO | BROADCOM INC | 1.8M | $551M | 3.14% | +99.4% |
| 13 | UNH | UNITEDHEALTH GROUP INC | 1.8M | $493M | 2.81% | +13.9% |
| 14 | SNPS | SYNOPSYS INC | 1.2M | $481M | 2.74% | +21.4% |
| 15 | BSX | BOSTON SCIENTIFIC CORP | 7.5M | $469M | 2.67% | +0.4% |
| 16 | TMO | THERMO FISHER SCIENTIFIC INC | 881.5K | $433M | 2.47% | +38.7% |
| 17 | KKR | KKR & CO INC | 4.7M | $432M | 2.46% | +131.5% |
| 18 | LNTH | LANTHEUS HLDGS INC | 5.6M | $424M | 2.41% | +2.9% |
| 19 | WAB | WABTEC | 1.6M | $402M | 2.29% | -35.0% |
| 20 | SCHW | SCHWAB CHARLES CORP | 4.0M | $372M | 2.12% | +18.4% |
| 21 | LQDA | LIQUIDIA CORPORATION | 8.7M | $327M | 1.86% | +0.0% |
| 22 | CRNX | CRINETICS PHARMACEUTICALS IN | 8.3M | $303M | 1.73% | +20.3% |
| 23 | GOOG | ALPHABET INC | 996.2K | $286M | 1.63% | +26.6% |
| 24 | ROIV | ROIVANT SCIENCES LTD | 9.7M | $268M | 1.53% | +26048.7% |
| 25 | V | VISA INC | 840.7K | $254M | 1.45% | +20.8% |
| 26 | ARMK | ARAMARK | 6.1M | $249M | 1.42% | -34.4% |
| 27 | BEAM | BEAM THERAPEUTICS INC | 10.1M | $242M | 1.38% | +0.7% |
| 28 | DIS | DISNEY WALT CO | 2.4M | $231M | 1.32% | -41.8% |
| 29 | MA | MASTERCARD INCORPORATED | 435.1K | $217M | 1.24% | +152.0% |
| 30 | MCK | MCKESSON CORP | 234.3K | $203M | 1.16% | -21.6% |
| 31 | AGIO | AGIOS PHARMACEUTICALS INC | 5.7M | $192M | 1.10% | +10.2% |
| 32 | CNTA | CENTESSA PHARMACEUTICALS PLC | 4.8M | $191M | 1.09% | -10.6% |
| 33 | TNGX | TANGO THERAPEUTICS INC | 9.1M | $190M | 1.08% | -30.4% |
| 34 | GRAL | GRAIL INC | 3.3M | $168M | 0.96% | +38.9% |
| 35 | TYRA | TYRA BIOSCIENCES INC | 3.6M | $137M | 0.78% | +73.3% |
| 36 | THC | TENET HEALTHCARE CORP | 452.2K | $85M | 0.49% | +21.5% |
| 37 | CAH | CARDINAL HEALTH INC | 368.0K | $78M | 0.44% | -36.1% |
| 38 | PCVX | VAXCYTE INC | 1.3M | $73M | 0.42% | +25120.0% |
| 39 | DNTH | DIANTHUS THERAPEUTICS INC | 836.0K | $70M | 0.40% | -- |
| 40 | BTSG | BRIGHTSPRING HEALTH SVCS INC | 1.6M | $69M | 0.39% | +7250.0% |
| 41 | TWST | TWIST BIOSCIENCE CORP | 1.4M | $68M | 0.39% | +18562.1% |
| 42 | BIDU | BAIDU INC | 443.8K | $49M | 0.28% | +40.8% |
| 43 | CGON | CG ONCOLOGY INC | 674.0K | $46M | 0.26% | +8325.0% |
| 44 | AZN | ASTRAZENECA PLC | 226.5K | $45M | 0.25% | -- |
| 45 | -- | VNET GROUP INC | 45.0M | $45M | 0.25% | -- |
| 46 | MRK | MERCK & CO INC | 361.0K | $43M | 0.25% | -- |
| 47 | ACHC | ACADIA HEALTHCARE COMPANY IN | 1.7M | $41M | 0.23% | -- |
| 48 | WELL | WELLTOWER INC | 200.0K | $40M | 0.23% | -41.7% |
| 49 | IMVT | IMMUNOVANT INC | 1.5M | $38M | 0.22% | +12783.3% |
| 50 | ENTA | ENANTA PHARMACEUTICALS INC | 2.9M | $36M | 0.21% | +3.6% |